Original
Determinación de linezolid en plasma mediante cromatografía líquida de alta resolución para la monitorización terapéutica en pacientes
Determination of linezolid in human plasma by high-performance liquid chromatography for therapeutic drug monitoring
Leído
5324
Vecesse ha leído el artículo
983
Total PDF
4341
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 14 | 9 | 23 |
| 2025 11 | 54 | 22 | 76 |
| 2025 10 | 75 | 9 | 84 |
| 2025 9 | 44 | 19 | 63 |
| 2025 8 | 47 | 15 | 62 |
| 2025 7 | 50 | 5 | 55 |
| 2025 6 | 54 | 2 | 56 |
| 2025 5 | 53 | 5 | 58 |
| 2025 4 | 41 | 13 | 54 |
| 2025 3 | 67 | 9 | 76 |
| 2025 2 | 45 | 14 | 59 |
| 2025 1 | 62 | 5 | 67 |
| 2024 12 | 37 | 9 | 46 |
| 2024 11 | 65 | 10 | 75 |
| 2024 10 | 58 | 9 | 67 |
| 2024 9 | 24 | 8 | 32 |
| 2024 8 | 26 | 4 | 30 |
| 2024 7 | 8 | 5 | 13 |
| 2024 6 | 0 | 9 | 9 |
| 2024 5 | 0 | 6 | 6 |
| 2024 4 | 0 | 6 | 6 |
| 2024 3 | 0 | 7 | 7 |
| 2024 2 | 0 | 4 | 4 |
| 2024 1 | 0 | 3 | 3 |
| 2023 12 | 0 | 5 | 5 |
| 2023 11 | 0 | 3 | 3 |
| 2023 10 | 0 | 5 | 5 |
| 2023 9 | 0 | 2 | 2 |
| 2023 8 | 0 | 2 | 2 |
| 2023 7 | 0 | 14 | 14 |
| 2023 6 | 0 | 4 | 4 |
| 2023 5 | 0 | 12 | 12 |
| 2023 4 | 0 | 2 | 2 |
| 2023 3 | 4 | 2 | 6 |
| 2023 2 | 0 | 7 | 7 |
| 2022 1 | 0 | 11 | 11 |
| 2022 12 | 0 | 1 | 1 |
| 2022 11 | 0 | 5 | 5 |
| 2022 10 | 0 | 1 | 1 |
| 2022 9 | 0 | 6 | 6 |
| 2022 8 | 0 | 5 | 5 |
| 2022 7 | 0 | 2 | 2 |
| 2022 6 | 16 | 14 | 30 |
| 2022 5 | 17 | 8 | 25 |
| 2022 4 | 33 | 16 | 49 |
| 2022 3 | 66 | 17 | 83 |
| 2022 2 | 30 | 5 | 35 |
| 2021 1 | 38 | 12 | 50 |
| 2021 12 | 59 | 21 | 80 |
| 2021 11 | 37 | 18 | 55 |
| 2021 10 | 53 | 19 | 72 |
| 2021 9 | 47 | 17 | 64 |
| 2021 8 | 17 | 8 | 25 |
| 2021 7 | 22 | 11 | 33 |
| 2021 6 | 27 | 13 | 40 |
| 2021 5 | 25 | 4 | 29 |
| 2021 4 | 38 | 21 | 59 |
| 2021 3 | 32 | 17 | 49 |
| 2021 2 | 51 | 11 | 62 |
| 2020 1 | 29 | 15 | 44 |
| 2020 12 | 41 | 12 | 53 |
| 2020 11 | 22 | 6 | 28 |
| 2020 10 | 29 | 10 | 39 |
| 2020 9 | 8 | 5 | 13 |
| 2020 8 | 10 | 11 | 21 |
| 2020 7 | 14 | 7 | 21 |
| 2020 6 | 15 | 11 | 26 |
| 2020 5 | 9 | 11 | 20 |
| 2020 4 | 4 | 8 | 12 |
| 2020 3 | 3 | 4 | 7 |
| 2020 1 | 0 | 6 | 6 |
| 2019 12 | 0 | 3 | 3 |
| 2019 11 | 0 | 1 | 1 |
| 2019 9 | 0 | 2 | 2 |
| 2019 7 | 0 | 7 | 7 |
| 2019 6 | 0 | 13 | 13 |
| 2019 5 | 0 | 31 | 31 |
| 2019 2 | 4 | 2 | 6 |
| 2018 8 | 1 | 0 | 1 |
| 2018 2 | 7 | 1 | 8 |
| 2018 1 | 10 | 1 | 11 |
| 2017 12 | 13 | 2 | 15 |
| 2017 11 | 20 | 1 | 21 |
| 2017 10 | 21 | 4 | 25 |
| 2017 9 | 23 | 4 | 27 |
| 2017 8 | 11 | 2 | 13 |
| 2017 7 | 14 | 2 | 16 |
| 2017 6 | 21 | 12 | 33 |
| 2017 5 | 26 | 10 | 36 |
| 2017 4 | 23 | 4 | 27 |
| 2017 3 | 31 | 20 | 51 |
| 2017 2 | 52 | 5 | 57 |
| 2016 1 | 21 | 0 | 21 |
| 2016 12 | 35 | 6 | 41 |
| 2016 11 | 30 | 5 | 35 |
| 2016 10 | 63 | 5 | 68 |
| 2016 9 | 110 | 8 | 118 |
| 2016 8 | 27 | 4 | 31 |
| 2016 7 | 37 | 3 | 40 |
| 2016 6 | 41 | 13 | 54 |
| 2016 5 | 35 | 6 | 41 |
| 2016 4 | 35 | 22 | 57 |
| 2016 3 | 42 | 15 | 57 |
| 2016 2 | 33 | 12 | 45 |
| 2015 1 | 24 | 12 | 36 |
| 2015 12 | 58 | 11 | 69 |
| 2015 11 | 31 | 8 | 39 |
| 2015 10 | 40 | 9 | 49 |
| 2015 9 | 22 | 7 | 29 |
| 2015 8 | 40 | 3 | 43 |
| 2015 7 | 46 | 3 | 49 |
| 2015 6 | 14 | 3 | 17 |
| 2015 5 | 28 | 2 | 30 |
| 2015 4 | 31 | 7 | 38 |
| 2015 3 | 45 | 5 | 50 |
| 2015 2 | 24 | 2 | 26 |
| 2015 1 | 41 | 3 | 44 |
| 2014 12 | 90 | 4 | 94 |
| 2014 11 | 55 | 5 | 60 |
| 2014 10 | 82 | 2 | 84 |
| 2014 9 | 61 | 3 | 64 |
| 2014 8 | 43 | 4 | 47 |
| 2014 7 | 72 | 2 | 74 |
| 2014 6 | 60 | 1 | 61 |
| 2014 5 | 63 | 2 | 65 |
| 2014 4 | 35 | 5 | 40 |
| 2014 3 | 58 | 3 | 61 |
| 2014 2 | 51 | 1 | 52 |
| 2014 1 | 58 | 4 | 62 |
| 2013 12 | 42 | 4 | 46 |
| 2013 11 | 46 | 5 | 51 |
| 2013 10 | 43 | 2 | 45 |
| 2013 9 | 0 | 1 | 1 |
| 2011 9 | 632 | 0 | 632 |
Mostrar todo
